Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Phys Rev Lett ; 132(17): 172302, 2024 Apr 26.
Article in English | MEDLINE | ID: mdl-38728735

ABSTRACT

This Letter presents the measurement of near-side associated per-trigger yields, denoted ridge yields, from the analysis of angular correlations of charged hadrons in proton-proton collisions at sqrt[s]=13 TeV. Long-range ridge yields are extracted for pairs of charged particles with a pseudorapidity difference of 1.4<|Δη|<1.8 and a transverse momentum of 1

2.
Eur J Gastroenterol Hepatol ; 31(10): 1173-1183, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31498278

ABSTRACT

Unambiguously, great progress has been achieved in the unraveling of more pathological pathways implicated in the development and progression of ulcerative colitis during the last decades. Novel effective drugs that have augmented the management armamentarium have been developed alongside this growing comprehension of the disease, rendering mucosal healing not only a feasible but the optimal goal of every therapy. Clinical evaluation, colonoscopy and biomarkers are the tools used by practitioners for the diagnosis and assessment of the status of the disease in order to achieve clinical remission and mucosal healing for their patients. Among these tools, colonoscopy is the gold method for the cause but is still an invasive, high-cost procedure with possible adverse events such as perforation. While clinical evaluation entails much subjectivity, biomarkers are objective, easily reproducible, non-invasive, cheap and potent surrogate tools of mucosal inflammation. Unfortunately, the well-established, currently in use serum biomarkers, such as C-reactive protein, erythrocyte sedimentation rate and others, do not display sufficiently acceptable sensitivity and specificity rates for the diagnosis of ulcerative colitis and, most importantly, do not represent precisely the mucosal inflammation status of the disease. Therefore, the discovery of new serum biomarkers has been the cause of several studies attempting to discover an "optimal" serum biomarker during the recent years. After thorough research, collection and examination of current data, this review focuses on and selectively presents promising, potential, novel serum biomarkers of ulcerative colitis as they are indicated by studies on the patient over the last years.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Biomarkers/blood , Colitis, Ulcerative/diagnosis , Colitis, Ulcerative/drug therapy , Colitis, Ulcerative/blood , Drug Monitoring , Humans
3.
J Laryngol Otol ; 127(4): 332-8, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23448505

ABSTRACT

AIM: To determine whether tonsillectomy improves quality of life in adults suffering from chronic or recurrent tonsillitis. METHOD: A systematic literature search of the Medline and Pubmed databases was conducted in order to identify all relevant studies measuring quality of life directly. RESULTS AND CONCLUSION: Eight studies were identified. The Glasgow Benefit Inventory and the Short Form questionnaire were the main tools used to assess quality of life changes. Tonsillectomy is likely to improve the overall quality of life as it particularly improves patients' physical and general health. The social benefits of tonsillectomy appear to be non-significant. The effects are likely to be long-lasting and have a greater impact on younger patients. The presence of coexisting chronic conditions and the severity of infective symptoms due to tonsillitis are also influencing factors.


Subject(s)
Health Status , Quality of Life , Tonsillectomy/psychology , Tonsillitis/psychology , Adolescent , Adult , Age Factors , Humans , Middle Aged , Tonsillitis/complications , Tonsillitis/surgery , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...